115 related articles for article (PubMed ID: 2139471)
1. Novel benzamides as selective and potent gastric prokinetic agents. 1. Synthesis and structure-activity relationships of N-[(2-morpholinyl)alkyl]benzamides.
Kato S; Morie T; Hino K; Kon T; Naruto S; Yoshida N; Karasawa T; Matsumoto J
J Med Chem; 1990 May; 33(5):1406-13. PubMed ID: 2139471
[TBL] [Abstract][Full Text] [Related]
2. Novel benzamides as selective and potent gastrokinetic agents. 2. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2- morpholinyl]methyl] benzamide citrate (AS-4370) and related compounds.
Kato S; Morie T; Kon T; Yoshida N; Karasawa T; Matsumoto J
J Med Chem; 1991 Feb; 34(2):616-24. PubMed ID: 1995885
[TBL] [Abstract][Full Text] [Related]
3. Novel benzamides as selective and potent gastrokinetic agents. III. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-methoxy- and 2-ethoxy-N-[(4-substituted 2-morpholinyl)methyl]-benzamides.
Kato S; Morie T; Harada H; Yoshida N; Matsumoto J
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):652-60. PubMed ID: 1535291
[TBL] [Abstract][Full Text] [Related]
4. Novel benzamides as selective and potent gastrokinetic agents. IV. Synthesis and structure-activity relationships of 2-substituted 4-amino-N-[(4-benzyl-2-morpholinyl)methyl]-5-chlorobenzamides.
Kato S; Morie T; Yoshida N; Matsumoto J
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1470-5. PubMed ID: 1394664
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
[TBL] [Abstract][Full Text] [Related]
6. AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties.
Yoshida N; Omoya H; Oka M; Furukawa K; Ito T; Karasawa T
Arch Int Pharmacodyn Ther; 1989; 300():51-67. PubMed ID: 2533479
[TBL] [Abstract][Full Text] [Related]
7. Substituted benzamides with conformationally restricted side chains. 1. Quinolizidine derivatives as selective gastric prokinetic agents.
Hadley MS; King FD; McRitchie B; Turner DH; Watts EA
J Med Chem; 1985 Dec; 28(12):1843-7. PubMed ID: 4068007
[TBL] [Abstract][Full Text] [Related]
8. Substituted benzamides with conformationally restricted side chains. 2. Indolizidine derivatives as central dopamine receptor antagonists.
King FD; Hadley MS; McClelland CM
J Med Chem; 1988 Sep; 31(9):1708-12. PubMed ID: 2900897
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-ethoxybenzamides with six- and seven-membered heteroalicycles as potential gastroprokinetic agents.
Morie T; Kato S; Harada H; Yoshida N; Fujiwara I; Matsumoto J
Chem Pharm Bull (Tokyo); 1995 Jul; 43(7):1137-47. PubMed ID: 7586057
[TBL] [Abstract][Full Text] [Related]
10. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
Högberg T; Ström P; de Paulis T; Stensland B; Csöregh I; Lundin K; Hall H; Ogren SO
J Med Chem; 1991 Mar; 34(3):948-55. PubMed ID: 1672158
[TBL] [Abstract][Full Text] [Related]
11. A new series of 6-chloro-2,3-dihydro-4(1H)-quinazolinone derivatives as antiemetic and gastrointestinal motility enhancing agents.
Baldazzi C; Barbanti M; Basaglia R; Benelli A; Bertolini A; Piani S
Arzneimittelforschung; 1996 Sep; 46(9):911-8. PubMed ID: 8876941
[TBL] [Abstract][Full Text] [Related]
12. Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice.
Suchitra AD; Dkhar SA; Shewade DG; Shashindran CH
World J Gastroenterol; 2003 Apr; 9(4):779-83. PubMed ID: 12679931
[TBL] [Abstract][Full Text] [Related]
13. Analysis of serotonergic mechanisms underlying benzamide-induced gastroprokinesis.
Linnik MD; Butler BT; Gaddis RR; Ahmed NK
J Pharmacol Exp Ther; 1991 Nov; 259(2):501-7. PubMed ID: 1941605
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and gastrointestinal prokinetic activity of novel benzamide derivatives with amphoteric side chains.
Sakaguchi J; Iwsaki N; Iwanaga Y; Saito T; Takahara E; Kato H; Hanaoka M
Chem Pharm Bull (Tokyo); 2001 Apr; 49(4):424-36. PubMed ID: 11310669
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activities of the optical isomers of (+/-)-4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2- morpholinyl]methyl]benzamide (mosapride).
Morie T; Kato S; Harada H; Yoshida N; Matsumoto J
Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):877-82. PubMed ID: 8020122
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro evaluation of 2,3-dimethoxy-5-(fluoroalkyl)-substituted benzamides: high-affinity ligands for CNS dopamine D2 receptors.
Bishop JE; Mathis CA; Gerdes JM; Whitney JM; Eaton AM; Mailman RB
J Med Chem; 1991 May; 34(5):1612-24. PubMed ID: 1827843
[TBL] [Abstract][Full Text] [Related]
17. KDR-5169, a new gastrointestinal prokinetic agent, enhances gastric contractile and emptying activities in dogs and rats.
Tazawa S; Masuda N; Koizumi T; Kitazawa M; Nakane T; Miyata H
Eur J Pharmacol; 2002 Jan; 434(3):169-76. PubMed ID: 11779580
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, gastrointestinal prokinetic activity and structure-activity relationships of novel N-[[2-(dialkylamino)ethoxy]benzyl]benzamide derivatives.
Sakaguchi J; Nishino H; Ogawa N; Iwanaga Y; Yasuda S; Kato H; Ito Y
Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):202-11. PubMed ID: 1576675
[TBL] [Abstract][Full Text] [Related]
19. Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent.
Park JS; Im W; Choi S; Park SJ; Jung JM; Baek KS; Son HP; Sharma S; Kim IS; Jung YH
Eur J Med Chem; 2016 Feb; 109():75-88. PubMed ID: 26761776
[TBL] [Abstract][Full Text] [Related]
20. Substituted benzamides. 1. Potential nondopaminergic antagonists of chemotherapy-induced nausea and emesis.
Monković I; Willner D; Adam MA; Brown M; Crenshaw RR; Fuller CE; Juby PF; Luke GM; Matiskella JA; Montzka TA
J Med Chem; 1988 Aug; 31(8):1548-58. PubMed ID: 3397992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
